Atlas Trials

Comparison Between Two Dose Levels of Daunorubicin and Between One vs. Two Induction Cycles for Adult Patients With AML

Clinical trial NCT02140242 · COMPLETED

Trial details

NCT number
NCT02140242
Sponsor
Technische Universität Dresden
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Leukemia, Myelocytic, Acute
Start date
2014-04-16
Primary completion
2022-04-25
Enrollment
721

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.